Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucosa of first-degree relatives of patients with gastric cancer

Abstract

Transforming growth factors beta (TGF-β) constitute a family of polypeptide growth factors that control cell growth, cell differentiation and migration, as well as the formation of the extracellular matrix. Recent analyses revealed the overexpression of TGF-β1 in human gastric cancers and demonstrated increased cell proliferation in the stomach of patients with gastric cancer and their first-degree relatives. Using human gastric tissues obtained from patients with gastric cancer (n = 19), biopsies from healthy first-degree relatives of gastric cancer patients (n = 18) and healthy individuals (n = 19), we analysed the expression of TGF-β1 using the reverse transcriptase polymerase chain reaction (RT-PCR) and immunohistochemistry. Fifteen of 19 patients with gastric cancer expressed TGF-β1 in the tumour. In 11 of these 15 cases TGF-β1 mRNA was also detectable in the non-tumourous stomach. Interestingly, all but two individuals with a first-degree relative diagnosed with gastric cancer exhibited TGF-β1 expression in either the antrum or corpus biopsy or both. In contrast, only one of 19 individuals without a family history of gastric cancer expressed TGF-β1 in the stomach (P< 0.0001). TGF-β1 expression is detectable in a large proportion of gastric cancers and in the stomach of healthy first-degree relatives of gastric cancer patients. Since individuals without gastric cancers in their family express TGF-β1 only in one of 19 cases, the induction of TGF-β1 expression in first-degree relatives of patients with gastric cancer points to the presence of specific molecular alterations in a subgroup of individuals with an increased risk of developing gastric cancer that may precede the development of gastric cancers. © 2000 Cancer Research Campaign

Change history

  • 16 November 2011

    This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

References

  1. Boeing H, Frentzel-Beyme R, Berger M, Berndt V, Göres W, Körner M, Lohmeier R, Menarcher A, Männl HFK, Müller R, Ostermeier H, Paul F, Schwemmle K, Wagner KH and Wahrendorf J (1991) Case–control study on stomach cancer in Germany. Int J Cancer 47: 858–864

  2. Correa P (1992) Human gastric carcinogenesis: a multistep and multifactorial process – first American Cancer Society Award Lecture on cancer epidemiology and prevention. Cancer Res 52: 6735–6740

  3. Delchier JC, Ebert M and Malfertheiner P (1998) Helicobacter pylori in gastric lymphoma and carcinoma. Curr Opin Gastroenterol 14: S41–S45

  4. Ebert M, Yokoyama M, Kobrin MS, Friess H, Lopez ME, Büchler MW and Korc M (1994) Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res 54: 3959–3962

  5. Ebert M, Yokoyama M, Friess H, Kobrin MS, Büchler M and Korc M (1995) Induction of platelet-derived growth factor A and B chains and overexpression of their receptors in human pancreatic cancer. Int J Cancer 62: 529–535

  6. Friess H, Yamanaka Y, Büchler MW, Ebert M, Beger HG, Gold LI and Korc M (1993) Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 105: 1846–1856

  7. Fuchs CS and Mayer RJ (1995) Gastric carcinoma. N Engl J Med 333: 32–41

  8. Kingsley D (1994) The TGF-β superfamily: new members, new receptors and new genetic tests of function in different organisms. Genes Dev 8: 133–146

  9. La Vecchia C, Negri E, Franceschi S and Gentile A (1992) Family history and the risk of stomach and colorectal cancer. Cancer 70: 50–55

  10. Macklin MT (1960) Inheritance of cancer of the stomach and large intestine in man. J Natl Cancer Inst 24: 551–571

  11. Mahara K, Kato J, Terui T, Takimoto R, Horimoto M, Murakami T, Mogi Y, Watanabe N, Kongo Y and Nutsu Y (1994) Transforming growth factor beta 1 secreted from scirrhous gastric cancer cells is associated with excess collagen deposition in the tissue. Br J Cancer 69: 777–783

  12. Massague J, Cheifetz S, Laiho M, Ralph DA, Weis FMB and Zentella A (1992) Transforming growth factor-β. Cancer Surv 12: 81–103

  13. Meining A, Hackelsberger A, Daenecke C, Stolte M, Bayerdörffer E and Ochsenkühn T (1998) Increased cell proliferation of the gastric mucosa in first degree relatives of gastric carcinoma patients. Cancer 83: 876–881

  14. Miehlke S, Hackelsberger A, Meining A, Hatz R, Lehn N, Stolte M and Bayerdörffer E (1997) Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Int J Cancer 73: 837–839

  15. Muso E, Yoshida H, Takeuchi E, Yashiro M, Matsushima H, Oyama A, Suyama K, Kawamura T, Kamata T, Miyawaki S, Izui S and Sasayama S (1996) Enhanced production of glomerular extracellular matrix in a new mouse strain of high serum IgA ddY mice. Kidney Int 50: 1946–1957

  16. Naef M, Ishiwata T, Friess H, Büchler MW, Gold LI and Korc M (1997) Differential localization of transforming growth factor-β isoforms in human gastric mucosa and overexpression in gastric carcinoma. Int J Cancer 71: 131–137

  17. Nakamura M, Katano M, Kuwahara A, Fujimoto K, Miyazaki K, Morisaki T and Mori M (1998) Transforming growth factor β1 (TGF-β1) is a preoperative prognostic indicator in advanced gastric carcinoma. Br J Cancer 78: 1373–1378

  18. Nakatsuru S, Yanagisawa A, Furukawa Y, Ichii S, Kato Y, Nakamura Y and Horii A (1993) Somatic mutations of the APC gene in precancerous lesions of the stomach. Hum Mol Genet 2: 1463–1465

  19. Ottini L, Palli D, Falchetti M, Dámico C, Amorosi A, Saieva C, Calzolari A, Cimoli F, Tatarelli C, De Marchis L, Masala G, Mariani-Costantini R and Cama A (1997) Microsatellite instability in gastric cancer is associated with tumor location and family history in a high-risk population from Tuscany. Cancer Res 57: 4523–4529

  20. Price AB (1991) The Sydney system: histological division. J Gastroenterol Hepatol 6: 209–222

  21. Siegel S (1956). Non-parametric Statistics for Behavorial Sciences, McGraw-Hill: New York

  22. Scott N, Landsdown M, Diament R, Rathbone B, Murday V, Wyatt JI, McMahou M, Dixon M and Quirke P (1990) Helicobacter gastritis and intestinal metaplasia in a gastric cancer family. Lancet 335: 728

  23. Soman NR, Wogan GN and Rhim JS (1990) TPR-MET oncogenic rearrangement: detection by polymerase chain reaction amplification of the transcript and expression in human tumor cell lines. Proc Natl Acad Sci USA 87: 738–742

  24. Tahara E, Semba M and Tahara H (1996) Molecular biological observations in gastric cancer. Semin Oncol 23: 307–315

  25. Wright PA, Quirke P, Attanoos R and Williams GT (1992) Molecular pathology of gastric carcinoma: progress and prospects. Hum Pathol 23: 848–859

Download references

Author information

Rights and permissions

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Reprints and Permissions

About this article

Cite this article

Ebert, M., Yu, J., Miehlke, S. et al. Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucosa of first-degree relatives of patients with gastric cancer. Br J Cancer 82, 1795–1800 (2000). https://doi.org/10.1054/bjoc.1999.1107

Download citation

Keywords

  • risk
  • screening
  • carcinogenesis
  • stomach
  • family

Further reading